Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Donaldson (DCI) Research & Development (2021 - 2026)

Donaldson filings provide 6 years of Research & Development readings, the most recent being $18.6 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 12.26% to $18.6 million in Q1 2026 year-over-year; TTM through Jan 2026 was $81.7 million, a 13.18% decrease, with the full-year FY2025 number at $87.8 million, down 6.2% from a year prior.
  • Research & Development hit $18.6 million in Q1 2026 for Donaldson, down from $19.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $25.4 million in Q3 2024 to a low of $16.6 million in Q1 2022.
  • Median Research & Development over the past 5 years was $21.2 million (2025), compared with a mean of $20.6 million.
  • Biggest five-year swings in Research & Development: surged 30.53% in 2024 and later dropped 15.42% in 2025.
  • Donaldson's Research & Development stood at $18.7 million in 2022, then grew by 13.9% to $21.3 million in 2023, then rose by 6.57% to $22.7 million in 2024, then dropped by 15.42% to $19.2 million in 2025, then decreased by 3.12% to $18.6 million in 2026.
  • The last three reported values for Research & Development were $18.6 million (Q1 2026), $19.2 million (Q4 2025), and $22.5 million (Q3 2025) per Business Quant data.